Annual Total Liabilities
$64.81 M
+$32.16 M+98.51%
December 31, 2022
Summary
- As of February 10, 2025, RXDX annual total liabilities is $64.81 million, with the most recent change of +$32.16 million (+98.51%) on December 31, 2022.
- During the last 3 years, RXDX annual total liabilities has fallen by -$22.65 million (-25.90%).
Performance
RXDX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$60.80 M
-$4.01 M-6.18%
March 31, 2023
Summary
- As of February 10, 2025, RXDX quarterly total liabilities is $60.80 million, with the most recent change of -$4.01 million (-6.18%) on March 31, 2023.
- Over the past year, RXDX quarterly total liabilities has increased by +$13.94 million (+29.75%).
Performance
RXDX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RXDX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.5% | +29.8% |
| 3 y3 years | -25.9% | - |
| 5 y5 years | -25.9% | - |
RXDX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -49.6% | -8.0% | -46.3% |
| 5 y | 5-year | -58.8% | -49.6% | -61.3% | -67.4% |
| alltime | all time | -58.8% | -49.6% | -61.3% | -67.4% |
Prometheus Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $60.80 M(-6.2%) |
| Dec 2022 | $64.81 M(+98.5%) | $64.81 M(-1.9%) |
| Sep 2022 | - | $66.08 M(+44.4%) |
| Jun 2022 | - | $45.76 M(-2.3%) |
| Mar 2022 | - | $46.86 M(+43.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $32.65 M(-79.2%) | $32.65 M(+21.6%) |
| Sep 2021 | - | $26.84 M(-12.7%) |
| Jun 2021 | - | $30.74 M(+55.2%) |
| Mar 2021 | - | $19.80 M(-87.4%) |
| Dec 2020 | $157.17 M(+79.7%) | $157.17 M |
| Dec 2019 | $87.45 M | - |
FAQ
- What is Prometheus Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Prometheus Biosciences?
- What is Prometheus Biosciences annual total liabilities year-on-year change?
- What is Prometheus Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly total liabilities year-on-year change?
What is Prometheus Biosciences annual total liabilities?
The current annual total liabilities of RXDX is $64.81 M
What is the all time high annual total liabilities for Prometheus Biosciences?
Prometheus Biosciences all-time high annual total liabilities is $157.17 M
What is Prometheus Biosciences annual total liabilities year-on-year change?
Over the past year, RXDX annual total liabilities has changed by +$32.16 M (+98.51%)
What is Prometheus Biosciences quarterly total liabilities?
The current quarterly total liabilities of RXDX is $60.80 M
What is the all time high quarterly total liabilities for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly total liabilities is $157.17 M
What is Prometheus Biosciences quarterly total liabilities year-on-year change?
Over the past year, RXDX quarterly total liabilities has changed by +$13.94 M (+29.75%)